BACKGROUND: Deep brain stimulation (DBS) of the subthalamic nucleus is an effective treatment for Parkinson disease. However, DBS is not responsive to an individual's disease state, and programming parameters, once established, do not change to reflect disease state. Local field potentials (LFPs) recorded from DBS electrodes are being investigated as potential biomarkers for the Parkinson disease state. However, no patient data exist about what happens to LFPs over the lifetime of the implant. OBJECTIVE: We investigated whether LFP amplitude and response to limb movement differed between patients implanted acutely with subthalamic nucleus DBS electrodes and patients implanted 2 to 7 years previously. METHODS: We recorded LFPs at DBS surgery time (9 subjects), 3 weeks after initial placement (9 subjects), and 2 to 7 years (median: 3.5) later during implanted programmable generator replacement (11 sides). LFP power-frequency spectra for each of 3 bipolar electrode derivations of adjacent contacts were calculated over 5-minute resting and 30-second movement epochs. Monopolar impedance data were used to evaluate trends over time. RESULTS: There was no significant difference in β-band LFP amplitude between initial electrode implantation (OR) and 3-week post-OR times (P=.94). However, β-band amplitude was lower at implanted programmable generator replacement times than in OR (P=.008) and post-OR recordings (P=.039). Impedance measurements declined over time (P<.001). CONCLUSION: Postoperative LFP activity can be recorded years after DBS implantation and demonstrates a similar profile in response to movement as during acute recordings, although amplitude may decrease. These results support the feasibility of constructing a closed-loop, patient-responsive DBS device based on LFP activity.
BACKGROUND: Deep brain stimulation (DBS) of the subthalamic nucleus is an effective treatment for Parkinson disease. However, DBS is not responsive to an individual's disease state, and programming parameters, once established, do not change to reflect disease state. Local field potentials (LFPs) recorded from DBS electrodes are being investigated as potential biomarkers for the Parkinson disease state. However, no patient data exist about what happens to LFPs over the lifetime of the implant. OBJECTIVE: We investigated whether LFP amplitude and response to limb movement differed between patients implanted acutely with subthalamic nucleus DBS electrodes and patients implanted 2 to 7 years previously. METHODS: We recorded LFPs at DBS surgery time (9 subjects), 3 weeks after initial placement (9 subjects), and 2 to 7 years (median: 3.5) later during implanted programmable generator replacement (11 sides). LFP power-frequency spectra for each of 3 bipolar electrode derivations of adjacent contacts were calculated over 5-minute resting and 30-second movement epochs. Monopolar impedance data were used to evaluate trends over time. RESULTS: There was no significant difference in β-band LFP amplitude between initial electrode implantation (OR) and 3-week post-OR times (P=.94). However, β-band amplitude was lower at implanted programmable generator replacement times than in OR (P=.008) and post-OR recordings (P=.039). Impedance measurements declined over time (P<.001). CONCLUSION: Postoperative LFP activity can be recorded years after DBS implantation and demonstrates a similar profile in response to movement as during acute recordings, although amplitude may decrease. These results support the feasibility of constructing a closed-loop, patient-responsive DBS device based on LFP activity.
Authors: Shay Moshel; Reuben R Shamir; Aeyal Raz; Fernando R de Noriega; Renana Eitan; Hagai Bergman; Zvi Israel Journal: Front Syst Neurosci Date: 2013-11-19
Authors: C Lungu; P Malone; T Wu; P Ghosh; B McElroy; K Zaghloul; T Patterson; M Hallett; Z Levine Journal: J Neurol Neurosurg Psychiatry Date: 2013-11-11 Impact factor: 10.154
Authors: Wolf-Julian Neumann; Franziska Staub-Bartelt; Andreas Horn; Julia Schanda; Gerd-Helge Schneider; Peter Brown; Andrea A Kühn Journal: Clin Neurophysiol Date: 2017-09-20 Impact factor: 3.708
Authors: David Escobar Sanabria; Luke A Johnson; Shane D Nebeck; Jianyu Zhang; Matthew D Johnson; Kenneth B Baker; Gregory F Molnar; Jerrold L Vitek Journal: J Neurophysiol Date: 2017-08-23 Impact factor: 2.714
Authors: AnneMarie K Brinda; Alex M Doyle; Madeline Blumenfeld; Jordan Krieg; Joseph S R Alisch; Chelsea Spencer; Emily Lecy; Lucius K Wilmerding; Adele DeNicola; Luke A Johnson; Jerrold L Vitek; Matthew D Johnson Journal: J Neural Eng Date: 2021-05-13 Impact factor: 5.379
Authors: Peter Brown; Andrea A Kühn; Wolf-Julian Neumann; Franziska Staub; Andreas Horn; Julia Schanda; Joerg Mueller; Gerd-Helge Schneider Journal: Neuromodulation Date: 2015-09-21
Authors: Roberto Martin Del Campo-Vera; Austin M Tang; Angad S Gogia; Kuang-Hsuan Chen; Rinu Sebastian; Zachary D Gilbert; George Nune; Charles Y Liu; Spencer Kellis; Brian Lee Journal: Neuromodulation Date: 2021-07-05